Guardian Pharmacy Services, Inc. (GRDN)

NYSE: GRDN · Real-Time Price · USD

40.29

-0.67 (-1.64%)

At close: Jul 13, 2026, 4:00 PM EDT

40.50

+0.21 (0.52%)

Pre-market: Jul 14, 2026, 7:29 AM EDT

GRDN Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,456	1,449	1,228	1,046	908.91	792.07
Revenue Growth (YoY)	13.54%	17.93%	17.42%	15.10%	14.75%	7.63%
Cost of Revenue	1,151	1,156	984.04	837.88	723.04	630.81
Gross Profit	304.68	292.72	244.37	208.31	185.87	161.27
Selling, General & Admin	227.31	220.02	307.29	167.36	133.88	118.09
Other Operating Expenses	-	-	-	-	-	13.03
Total Operating Expenses	227.31	220.02	307.29	167.36	133.88	131.12
Operating Income	12.58	72.7	-62.92	40.95	51.99	30.15
Interest Expense	-0.33	-0.67	-3.28	-2.86	-1.93	-1.64
Other Non-Operating Income (Expense)	0.62	1.39	-0.28	-0.37	-0.4	-0.19
Total Non-Operating Income (Expense)	0.28	0.72	-3.56	-3.23	-2.33	-1.82
Pretax Income	12.59	73.42	-66.48	37.72	49.66	28.33
Provision for Income Taxes	25.38	24.47	4.56	-	-	-
Net Income	8.83	48.96	-71.03	37.72	49.66	28.33
Minority Interest in Earnings	0.16	-0.26	39.01	37.72	-14.24	-12.01
Net Income to Common	9.03	49.22	-110.05	0	35.42	16.31
Net Income Growth	-	-	-	-	117.12%	-18.20%
Shares Outstanding (Basic)	63	62	62	0	0	0
Shares Outstanding (Diluted)	63	63	62	0	0	0
Shares Change (YoY)	0.32%	2.08%	62005700.00%	-	-	-
EPS (Basic)	0.85	0.79	-1.77	-	354210.00	163140.00
EPS (Diluted)	0.83	0.78	-1.77	-	354210.00	163140.00
EPS Growth	-	-	-	-	117.12%	-
Free Cash Flow	70.01	80.71	41.59	56.26	31.75	49.22
Free Cash Flow Growth	-13.26%	94.05%	-26.08%	77.20%	-35.48%	11.17%
Free Cash Flow Per Share	1.10	1.28	0.67	562630.00	317520.00	492160.00
Gross Margin	20.93%	20.21%	19.89%	19.91%	20.45%	20.36%
Operating Margin	0.86%	5.02%	-5.12%	3.91%	5.72%	3.81%
Profit Margin	0.61%	3.38%	-5.78%	3.61%	5.46%	3.58%
FCF Margin	4.81%	5.57%	3.39%	5.38%	3.49%	6.21%
EBITDA	29.88	95.04	-43.15	59.18	68.55	46.68
EBITDA Margin	2.05%	6.56%	-3.51%	5.66%	7.54%	5.89%
EBIT	12.58	72.7	-62.92	40.95	51.99	30.15
EBIT Margin	0.86%	5.02%	-5.12%	3.91%	5.72%	3.81%
Effective Tax Rate	201.64%	33.32%	-6.85%	0.00%	0.00%	0.00%

SEC Filings: 10-K · 10-Q